ARHGEF17 and neoplasm: Given the central role played by Rho GTPases at various stages of tumor progression, our studies set the ground for future investigations aiming to address whether ARHGEF17 is a common effector of Gβγ-dependent signaling pathways elicited by chemotactic GPCRs within the tumor microenvironment.